|
Interactive Case Studies based on the Satellite Symposium held on April 28, 2011 in conjunction with the 36th Annual Oncology Nursing Society Congress.
Release Date: November 2011
CE Available Until: November 30, 2012
Supported by an educational grant from Cephalon, Inc. |
|
Intended Audience
This continuing education activity is designed for nurses involved in the management of cancer pain.
Rationale and Purpose
The overall purpose of this educational activity is to present the knowledge health care providers need to better understand the importance of managing BTCP, and to provide potential strategies for application to their clinical practices. This activity will help reduce barriers that prevent the integration of therapies into practice and will support adherence to current guidelines.
Learning Objectives
At the completion of this activity, participants should be better able to
- Explain BTCP pathophysiology, characteristics, and impact on patients
- Discuss assessment strategies for BTCP
- Describe approved and investigational agents for treatment of BTCP, including their benefits and limitations
- Discuss strategies to promote safe use of opioids for BTCP, including Risk Evaluation and Mitigation Strategy (REMS) programs
Continuing Education
To access the learning assessment and evaluation form online, visit: BTCPVL2011.cme360.net
Statement of Credit—Participants who successfully complete this activity (including scoring at least 70% on the learning assessment and completing and submitting the evaluation form) will be issued a statement of credit via e-mail within 4 weeks.
 Nurses. This activity for 1.5 contact hour(s) is provided by the Meniscus Educational Institute.
The Meniscus Educational Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation refers to recognition of educational activities only and does not imply approval or endorsement by the Meniscus Educational Institute or the American Nurses Credentialing Center’s Commission on Accreditation of any product mentioned.
Provider approved by the California Board of Registered Nursing, Provider No. 13164, for 1.5 contact hours.
Financial Disclosures
All individuals in positions to control the content of this program (eg, planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity. All faculty have been offered a modest honorarium from the accredited provider for their participation in this activity.
Jeannine M. Brant, PhD, APRN, AOCN, Author, receives honoraria from Genentech.
Carol P. Curtiss, MSN, RN, BC, Author, serves as an advisor and speaker for, and receives honoraria from, Meda Pharmaceuticals, Pfizer, and Salix.
Virginia R. Martin, MSN, RN, AOCN, Education Committee Reviewer, has nothing to disclose.
Karen Abbas, RN, MSN, AOCN, Nurse Planner, has nothing to disclose.
Reylon Meeks RN, MS, MSN, EMT, PhDc, Pilot Reviewer, has nothing to disclose.
Dawn Stefanik, RN, Pilot Reviewer, has nothing to disclose.
Disclaimer
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Meniscus Educational Institute educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.
The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by MEI of any specific therapeutics or approaches to diagnosis or patient management.
Product Disclosure
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.
THERE IS NO FEE FOR PARTICIPATING IN THIS ACTIVITY.
|
The Accreditation Program of the American Nurses Credentialing Center is interested in the opinions and perspectives of the participants in accredited continuing nursing education activities, particularly perspectives related to the presence of perceived bias* in an activity. For this reason, we provide a toll-free telephone number, which participants may call at any time to tell us about
- Any noted bias or conflict of interest in the education
- Any concerns, compliments, or opinions
- A great experience
- An unpleasant experience
- Your thoughts on the process
Just call and tell us!
1-866-262-9730
*Bias is defined as preferential influence that causes a distortion of opinion or facts. Commercial bias may occur when an educational activity promotes one or more product(s) (drugs, devices, services, software, hardware, etc). This definition is not all inclusive, and participants may use their own interpretation in deciding whether a presentation is biased.
NOTE: statements of commercial support and/or conflict of interest disclosures do not represent bias. Such statements inform the learner that the provider has implemented a mechanism to identify and resolve all conflicts of interest prior to delivery of the educational material.
|
Point of Care Tools
Pain Management Resources
City of Hope Pain & Palliative Care Resource Center
Opioid Analgesic Conversion Chart
Evaluating Pain in Non‐communicative Persons
Checklist of Nonverbal Pain Indicators (CNPI)
Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP®-R)
Current Opioid Misuse Measure (COMM)®
Brief Pain Inventory (Short Form)
Pain Management Pocket Tool
Download Activity
Select “Yes” if you have reviewed the CE information above and would like to proceed to download the case studies.
Yes
No |
[back to the top]
|
